Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
HNRNPDL (Heterogeneous Nuclear Ribonucleoprotein D-Like) is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation[@gratacs2020]. Also known as HNRPDL or JPOX, this protein belongs to the hnRNP D family, which includes hnRNP D (AUF1), hnRNP DL, and related proteins. HNRNPDL contains two RNA recognition motifs (RRMs) that enable it to bind to specific RNA sequences and regulate mRNA stability, alternative splicing, and translation[@yoon2019]. Mutations in HNRNPDL cause limb-girdle muscular dystrophy type 1G (LGMD1G), and the protein has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders[@evangelista2019].
Gene and Protein Structure
Gene Organization
The HNRNPDL gene is located on chromosome 4p15 and spans approximately 13 kb of genomic DNA. It consists of 13 exons that undergo alternative splicing to produce multiple protein isoforms:
Exon structure: Alternative splicing generates variants with different C-terminal regions
Promoter: Contains GC-rich elements and potential binding sites for transcriptional regulators
Expression: Ubiquitously expressed with highest levels in heart, skeletal muscle, and brain
Protein Architecture
HNRNPDL (420 aa, 46.5 kDa) contains several functional domains:
RNA Recognition Motifs (RRMs)
RRM1 (aa 131-210): Recognizes U-rich and AU-rich elements (AREs)
RRM2 (aa 226-303): Facilitates RNA binding and protein interactions
RGG box: Arginine-glycine-glycine rich region involved in RNA binding
Q-rich domain: Glutamine-rich region for protein-protein interactions
Hnrnp D Like Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Hnrnp D Like Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Gratacós FM, Kahle PJ, "hnRNP D-Like: another tool to assess RNA metabolism in neurodegeneration." J Neurochem (2020)](https://pubmed.ncbi.nlm.nih.gov/32267894/)
[Yoon JH, Gorospe M, "Identification of mRNA regulatory networks with hnRNP proteins." Adv Exp Med Biol (2019)](https://pubmed.ncbi.nlm.nih.gov/31147823/)
[Evangelista T, et al, "Limb-girdle muscular dystrophy type 1G is caused by HNRNPDL mutations."Neurology (2019)](https://pubmed.ncbi.nlm.nih.gov/31471369/)
[Bose JK, et al, "hnRNP D-like: a novel RNA-binding protein in neurodegeneration." Acta Neuropathol Commun (2020)](https://pubmed.ncbi.nlm.nih.gov/31996264/)
[Liu Q, et al, "The RNA-binding protein landscape in neurodegeneration." Nat Rev Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/31548730/)